Cyclerion Therapeutics, Inc.·4

Jan 26, 4:07 PM ET

Hecht Peter M 4

4 · Cyclerion Therapeutics, Inc. · Filed Jan 26, 2024

Insider Transaction Report

Form 4
Period: 2024-01-01
Hecht Peter M
Director10% Owner
Transactions
  • Award

    Common Stock

    2024-01-01+15,000377,385 total
Holdings
  • Common Stock

    (indirect: By Trust)
    24
  • Common Stock

    (indirect: By Trust)
    24
  • Common Stock

    (indirect: By Trust)
    24
Footnotes (2)
  • [F1]The Reporting Person was granted 15,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan. These 15,000 shares are subject to vesting over a 47- month period, provided that the Reporting Person remains a consultant to the Cyclerion Therapeutics or a member of the board of directors of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.
  • [F2]These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4